DrugDashboards

Olopatadine Hydrochloride

Olopatadine Hydrochloride · OLOPATADINE HYDROCHLORIDE 2 mg/mL · Solution/ Drops · Ophthalmic · Somerset Therapeutics, LLC

NDC 70069-0491-01 · 1 BOTTLE, PLASTIC in 1 CARTON / 2.5 mL in 1 BOTTLE, PLASTIC · ANDA · View full market →

The short version

11 companies supply this market — deep enough that no single failure threatens the supply. The price is down 17% over the past year, to $3.00 per mL. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$2.00$4.00Jul 2025Sep 2026$3.00
15 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$8.75
Reported to Texas DSHS · 2026 annual filing · Somerset Therapeutics, LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$271,084
15,747 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for olopatadine hydrochloride (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA215006
TE code
Approval date
Dec 18, 2024
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Olopatadine Hydrochloride (Solution/ Drops)

LabelerStrengthFirst seenLast seen
Alembic Pharmaceuticals LimitedOLOPATADINE HYDROCHLORIDE 1 mg/mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedOLOPATADINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Allegiant HealthOLOPATADINE HYDROCHLORIDE 1 mg/mLJul 15, 2026Sep 2, 2026
Apotex Corp.OLOPATADINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Apotex Corp.OLOPATADINE HYDROCHLORIDE 1 mg/mLJul 15, 2026Sep 2, 2026
Cardinal Health 110, Llc. Dba LeaderOLOPATADINE HYDROCHLORIDE 1 mg/mLJul 15, 2026Sep 2, 2026
Cardinal Health 110, Llc. Dba LeaderOLOPATADINE HYDROCHLORIDE 7 mg/mLJul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.OLOPATADINE HYDROCHLORIDE 1 mg/mLJul 15, 2026Sep 2, 2026
OCuSOFT LLCOLOPATADINE HYDROCHLORIDE 5 mg/2.5mLJul 15, 2026Sep 2, 2026
Rugby LaboratoriesOLOPATADINE HYDROCHLORIDE 7 mg/mLJul 15, 2026Sep 2, 2026
Rugby LaboratoriesOLOPATADINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Somerset Therapeutics, LLCOLOPATADINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Target CorporationOLOPATADINE HYDROCHLORIDE 7 mg/mLAug 18, 2026Sep 1, 2026
Alembic Pharmaceuticals Inc.OLOPATADINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Aug 31, 2026
Alembic Pharmaceuticals Inc.OLOPATADINE HYDROCHLORIDE 1 mg/mLJul 15, 2026Aug 31, 2026
Dr. Reddy's Laboratories Inc.OLOPATADINE HYDROCHLORIDE 7 mg/mLJul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Olopatadine Hydrochloride — NDC 70069-0491-01," retrieved September 3, 2026, https://drugdashboards.com/drug/70069049101.

Free to cite with attribution — see how the data is put together.